本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Rocket Pharmaceuticals, Inc.

2.90
+0.02000.69%
盘后2.87-0.0266-0.92%16:55 EDT
成交量:174.90万
成交额:508.66万
市值:3.12亿
市盈率:-1.11
高:2.96
开:2.91
低:2.85
收:2.88
数据加载中...
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/28

重要事件披露

Form 8-K - Current report
2025/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/12

重要事件披露

Form 8-K - Current report
2024/12/05

重要事件披露

Form 8-K - Current report
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities